Status:
COMPLETED
Nonmyeloablative Stem Cell Transplant in Elderly
Lead Sponsor:
Azienda Ospedaliera San Giovanni Battista
Conditions:
Hematological Malignancies
Eligibility:
All Genders
60+ years
Phase:
PHASE2
PHASE3
Brief Summary
The study aimed to evaluate the efficacy of a nonmyeloablative conditioning consisting of fludarabine and total body irradiation in patients older than 60 years of age
Detailed Description
A total of 35 patients with hematological malignancies were treated with fludarabine (30 mg/m2 x 3-5 days) and 200 cCy TBI followed by allogeneic hematopoietic stem cell transplantation (HSCT) from a ...
Eligibility Criteria
Inclusion
- patients with myeloid or lymphoid malignancy who were \> 60 years old potentially treatable with stem cell transplant
Exclusion
- lack of an HLA-identical sibling donor
Key Trial Info
Start Date :
March 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00382759
Start Date
March 1 2000
End Date
March 1 2007
Last Update
August 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Giovanni Battista
Torino, Italy, 10126